The data privacy landscape in the U.S. is continuing to change rapidly.
U.S. President Donald Trump touted progress in the fight against opioid abuse and promised to hold drugmakers accountable for their part in the crisis, a day after his administration brought its first related criminal charges against a major drug distributor and company executives.
President Donald Trump is expected to tout his fight against opioid abuse in remarks in Atlanta a day after his administration brought its first related criminal charges against a major drug distributor and company executives.
The White House is expanding its war on opioid addiction with a $350 million addiction research and treatment initiative.
Roche lifted the Swiss drugmaker’s 2019 outlook as sales growth in China and the United States outpaced price declines the company has suffered amid President Donald Trump’s pressure on the industry to hold down charges.
U.S. Senator Bernie Sanders unveiled the latest version of his ambitious “Medicare-for-All” plan, moving the healthcare debate among Democratic presidential contenders to center stage in the 2020 race.
Democrats embraced U.S. President Donald Trump’s call to revive a fight over healthcare coverage, ensuring a prominent role for the issue in the 2020 election as Trump seeks a second term in office.
China will expand the range of fentanyl-related substances the country defines as controlled narcotics, a Chinese security official said, blaming U.S. culture for abuse of the drug.
U.S. President Donald Trump is willing to work with congressional Democrats to lower drug prices for Americans and on infrastructure funding, White House adviser Kellyanne Conway said.
FDA Commissioner Scott Gottlieb plans to step down in April 2019, a sudden resignation that calls into question how the regulatory agency will handle issues such as surging e-cigarette use among teens and efforts to increase competition in prescription drugs.